To further address the key issues of technological innovation in the bioactive peptides and specialty food industries, carry out technological cooperation, accelerate the transfer and transformation of scientific and technological achievements, enhance the overall competitiveness of the industry, and provide talent support for sustained innovation in the industry, On April 20-22, 2023, the "2023 Bioactive Peptides and Special Medical Food Technology Innovation and Development Forum" Et "primum annui conventu specialis medicinae cibum et bioactive peptides operantes committee et instauratio conferentia ex peritos committee" sunt prospere tenuit in Guangzhou. Taiai Peptide Group, ut Vice Praesidem unitas et Vice Praesidem unitas invitavit ad hoc foro. Conference invitavit principes a relevant nationalibus departments, industria clarus experts et scholarium, et egregie enarrantibus repraesentativis dare orationes et concurrere in thematic commutationibus.
De mane 20, in "MMXXIII bioactive peptides et peculiari medicinae cibum technology innovation et progressionem foro" et "primi annua conventu specialis medicinae cibum et bioactive operantes committee et instauratione off.
De 21, Wen Kai, Secretarius Generalis specialis medicinae cibum et bioactive peptides operantes committee, consideratum annua exemplarization. Taiai peptide coetus vicit titulo de "2021-2022 Exemplar Organization." Zhang Jenny, Praeses Taiai peptide coetus, ut repraesentativum annui exemplarimoniae organization, fecit orationem: respiciens ad tres annos ad magnum salutem industria et lacus industria, providentes magis progressionem spatium et occasiones ad Peptide industria Post XXVI annis innovative progressionem, taiai peptide coetus est penitus colendi et innovating in peptide agri, adhaerens ad integritatem et innovation, et profecta est industria exemplum providere certa products pro populo; And taking advantage of this conference, we will work together with numerous enterprises to accelerate the development and innovation of China's active peptide industry in the future, achieve a new situation of co construction, win-win, and sharing, serve the peptide industry well, and strive to build a national owned brand. In global scaena magni salutem, testimonium perhibemus fortitudinem Sinis scriptor "peptide" Brand!
Subsequently, Mr. Ren Yandong, a medical consultant of Taiai Peptide Group and a dual doctoral degree in Traditional Chinese Medicine and Clinical Nutrition, also gave a wonderful sharing on the theme of "Health Management and International Clinical Nutrition Development Trends - Peptides" at this forum, discussing the relationship between peptides and proteins, amino acids, peptides and clinical nutrition, as well as the clinical practice of peptide Volume altum nutritionem.
Nam bioactive peptides et peculiari cibum industria, hoc est inordinatum internationalis res. Sine dubio, quia super centum annis, scientists, peritorum et professores ex variis regionibus et studiosissime se ad investigationis activae peptides, cum dives scientific investigationibus res res gestae. In futuro, Taiai peptide coetus erit altius et investigationis et applicationem in agro peptides, comprehendendo amplio et optimize ex aspectibus ut qualitas, in in peptide et in altiorem et magis professional planum. In global scaena magni valetudinis, quod narrabit fabulam de Chinese peptide brands bene.
Post tempus: May-04-2023